Predominant Api m 10 sensitization as risk factor for treatment failure in honey bee venom immunotherapy
2016 ◽
Vol 138
(6)
◽
pp. 1663-1671.e9
◽
2013 ◽
Vol 1
(6)
◽
pp. 687-688
◽
Keyword(s):
240 IgG1, IgG4 and IgE antibodies anti honey bee venom produced during honey bee venom immunotherapy
1991 ◽
Vol 87
(1)
◽
pp. 198
2020 ◽
Vol 30
(4)
◽
pp. 296-298
◽
Keyword(s):
2017 ◽
Vol 139
(2)
◽
pp. AB151
◽